The current situation in medicine has been described as a crisis of credibility, as the profit motive of industry has taken control of clinical trials and the dissemination of data. Pharmaceutical companies maintain a stranglehold over the content if . . .

Selective reporting is prevalent in the medical literature, particularly in industry-sponsored research. In this paper, we expose selective reporting that is not evident without access to internal company documents. The published report of study 329 o . . .

Commentators on Whitehead's philosophy often mention his mathematical background as a foundation for his metaphysics. Rarely, how ever do they explain just how the rigorous and technical expertise of his early work finds its relevant applications in h . . .

The present study attempts to examine the affinities and contrasts in the metaphysical systems of A. N. Whitehead and F. H. Bradley. As a comparative analysis, however, the study does not attempt to give equal attention to every aspect of both thinker . . .

Despite growing concern about medical ghostwriting, pharmaceutical companies, universities, medical journals, and communication companies employing ghostwriters have thus far failed to adequately stem the problem. As a result, some commentators have p . . .

The current situation in medicine has been described as a crisis of credibility, as the profit motive of industry has taken control of clinical trials and the dissemination of data. Pharmaceutical companies maintain a stranglehold over the content if . . .

The very idea of a basis for comparing the philosophies of W.V. Quine and A.N. Whitehead may be surprising to most philosophers, including Quine himself. Both produced systems of thought that have taken philosophy in two completely different direction . . .

Alfred North Whitehead advanced a version of multiverse theory in 19291 that bears a remarkable affinity to the revolutionary ideas of current cosmological speculation. He postulated his theory for some of the very same reasons as those advanced today . . .